Your browser doesn't support javascript.
loading
Development of recombinant COVID-19 vaccine based on CHO-produced, prefusion spike trimer and alum/CpG adjuvants.
Liu, Haitao; Zhou, Chenliang; An, Jiao; Song, Yujiao; Yu, Pin; Li, Jiadai; Gu, Chenjian; Hu, Dongdong; Jiang, Yuanxiang; Zhang, Lingli; Huang, Chuanqi; Zhang, Chao; Yang, Yunqi; Zhu, Qianjun; Wang, Dekui; Liu, Yuqiang; Miao, Chenyang; Cao, Xiayao; Ding, Longfei; Zhu, Yuanfei; Zhu, Hua; Bao, Linlin; Zhou, Lingyun; Yan, Huan; Fan, Jiang; Xu, Jianqing; Hu, Zhongyu; Xie, Youhua; Liu, Jiangning; Liu, Ge.
Afiliação
  • Liu H; Shanghai Zerun Biotechnology Co., Ltd., Shanghai, China.
  • Zhou C; Shanghai Zerun Biotechnology Co., Ltd., Shanghai, China.
  • An J; Shanghai Zerun Biotechnology Co., Ltd., Shanghai, China.
  • Song Y; Shanghai Zerun Biotechnology Co., Ltd., Shanghai, China.
  • Yu P; Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing, China.
  • Li J; Shanghai Zerun Biotechnology Co., Ltd., Shanghai, China.
  • Gu C; Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Department of Medical Microbiology and Parasitology, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.
  • Hu D; Shanghai Zerun Biotechnology Co., Ltd., Shanghai, China.
  • Jiang Y; Shanghai Zerun Biotechnology Co., Ltd., Shanghai, China.
  • Zhang L; Shanghai Zerun Biotechnology Co., Ltd., Shanghai, China.
  • Huang C; Shanghai Zerun Biotechnology Co., Ltd., Shanghai, China.
  • Zhang C; Shanghai Zerun Biotechnology Co., Ltd., Shanghai, China.
  • Yang Y; Shanghai Zerun Biotechnology Co., Ltd., Shanghai, China.
  • Zhu Q; Shanghai Zerun Biotechnology Co., Ltd., Shanghai, China.
  • Wang D; Shanghai Zerun Biotechnology Co., Ltd., Shanghai, China.
  • Liu Y; Shanghai Zerun Biotechnology Co., Ltd., Shanghai, China.
  • Miao C; Shanghai Zerun Biotechnology Co., Ltd., Shanghai, China.
  • Cao X; Shanghai Zerun Biotechnology Co., Ltd., Shanghai, China.
  • Ding L; Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.
  • Zhu Y; Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Department of Medical Microbiology and Parasitology, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.
  • Zhu H; Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing, China.
  • Bao L; Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing, China.
  • Zhou L; Shanghai Zerun Biotechnology Co., Ltd., Shanghai, China.
  • Yan H; State Key Laboratory of Virology, Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan, China.
  • Fan J; Shanghai Zerun Biotechnology Co., Ltd., Shanghai, China.
  • Xu J; Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.
  • Hu Z; National Institute for Food and Drug Control (NIFDC), Beijing, China. Electronic address: huzy67@163.com.
  • Xie Y; Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Department of Medical Microbiology and Parasitology, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai, China. Electronic address: yhxie@fudan.edu.cn.
  • Liu J; Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing, China. Electronic address: liujn@cnilas.org.cn.
  • Liu G; Shanghai Zerun Biotechnology Co., Ltd., Shanghai, China. Electronic address: liuge@walvax.com.
Vaccine ; 39(48): 7001-7011, 2021 11 26.
Article em En | MEDLINE | ID: mdl-34750014
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Limite: Animals / Humans Idioma: En Revista: Vaccine Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Limite: Animals / Humans Idioma: En Revista: Vaccine Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Holanda